Hyperglycaemia acutely decreases circulating dehydroepiandrosterone levels in healthy men

Clinical Endocrinology

Volumn 64, Issue 1, 2006, Pages 46-52

  Boudou, P ^a,b,c   Sobngwi, E ^a,b   Ibrahim, F ^a   Porcher, R ^a   Vexiau, P ^a,b   Calvo, F ^a   Gautier, J F ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYPREGNENOLONE; CORTICOSTEROID; FAT; GLUCOSE; INSULIN; PRASTERONE; PRASTERONE SULFATE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY FAT; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; HORMONE DETERMINATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULINEMIA; MALE; MULTIVARIATE ANALYSIS; NONLINEAR SYSTEM; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEROID BLOOD LEVEL; STEROID METABOLISM; UNIVARIATE ANALYSIS; VARIANCE; WAIST CIRCUMFERENCE;

17-ALPHA-HYDROXYPREGNENOLONE; ADULT; ANALYSIS OF VARIANCE; ANDROGENS; BLOOD GLUCOSE; BODY COMPOSITION; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; STATISTICS, NONPARAMETRIC;

EID: 33644962273     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02414.x     Document Type: Article

References (46)

1. Gurnell E.M. Chatterjee V.K. 2001 Dehydroepiandrosterone replacement therapy European Journal of Endocrinology 145 103 106
2. Allolio B. Arlt W. 2002 DHEA treatment: myth or reality? Trends in Endocrinology and Metabolism 13 288 294
3. Barrett-Connor E. Khaw K.T. Yen S.S. 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease New England Journal of Medicine 315 1519 1524
4. Feldman H.A. Johannes C.B. Araujo A.B. Mohr B.A. Longcope C. McKinlay A.B. 2001 Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study American Journal of Epidemiology 1 79 89
5. Garcia M.J. McNamara P.M. Gordon T. Kannel W.B. 1974 Morbidity and mortality in diabetics in the Framingham population. Sixteen-year follow-up study Diabetes 23 105 111
6. Stamler J. Vaccaro O. Neaton J.D. Wentworth D. 1993 Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 434 444
7. Barrett-Connor E. 1992 Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus Annals of Internal Medicine 117 807 811
8. Yamauchi A. Takei I. Kasuga A. Kitamura Y. Ohashi N. Nakano S. Takayama S. Nakamoto S. Katsukawa F. Saruta T. 1996 Depression of dehydroepiandrosterone in Japanese diabetic men comparison between non-insulin-dependent diabetes mellitus and impaired glucose tolerance European Journal of Endocrinology 135 101 104
9. Tagawa N. Ohta M. Nakamura N. Nakano K. Obayashi H. Kobayashi Y. 2002 Serum concentrations of delta 5-3 beta-hydroxysteroids in type 2 diabetes mellitus Biological & Pharmaceutical Bulletin 25 1634 1638
10. Barrett-Connor E. Goodman-Gruen D. 1995 The epidemiology of DHEAS and cardiovascular disease Annals of the New York Academy of Sciences 29 259 270
11. Tchernof A. Despres J.P. Belanger A. Dupont A. Prud'homme D. Moorjani S. Lupien P.J. Labrie F. 1995 Reduced testosterone and adrenal C19 steroid levels in obese men Metabolism 44 513 519
12. Tchernof A. Despres J.P. Dupont A. Belanger A. Nadeau A. Prud'homme D. Moorjani S. Lupien P.J. Labrie F. 1995 Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue Diabetes Care 18 292 299
13. Tchernof A. Labrie F. Belanger A. Prud'homme D. Bouchard C. Tremblay A. Nadeau A. Despres J.P. 1997 Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men Journal of Clinical Endocrinology and Metabolism 82 1528 1534
14. Haffner S.M. Valdez R.A. Mykkanen L. Stern M.P. Katz M.S. 1994 Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men Metabolism 43 599 603
15. Denti L. Pasolini G. Sanfelici L. Ablondi F. Freddi M. Benedetti R. Valenti G. 1997 Effects of aging on dehydroepiandrosterone sulfate in relation to fasting insulin levels and body composition assessed by bioimpedance analysis Metabolism 46 826 832
16. Nestler J.E. Whitfield J.B. Williams T.Y. Zhu G. Con don J. Kirk K.M. Heath A.C. Montgomery G.W. Martin N.G. 2002 Genetics of serum dehydroepiandrosterone sulfate and its relationship to insulin in a population-based cohort of twin subjects Journal of Clinical Endocrinology and Metabolism 87 682 686
17. Benbassat C.A. Maki K.C. Unterman T.G. 1997 Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures Journal of Clinical Endocrinology and Metabolism 82 1484 1491
18. Boudou P. De Kerviler E. Vexiau P. Fiet J. Cathelineau G. Gautier J.F. 2000 Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status Diabetes & Metabolism 26 450 457
19. Kiechl S. Willeit J. Bonora E. Schwarz S. Xu Q. 2000 No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study Arteriosclerosis, Thrombosis, and Vascular Biology 20 1094 1100
20. Nestler J.E. Usiskin K.S. Barlascini C.O. Welty D.F. Clore J.N. Blackard W.G. 1989 Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms Journal of Clinical Endocrinology and Metabolism 69 1040 1046
21. Ebeling P. Stenman U.H. Seppälä M. Koivisto V.A. 1995 Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man Journal of Endocrinology 146 63 69
22. Yamaguchi Y. Tanaka S. Yamakawa T. Kimura M. Ukama K. Yamada Y. Ishihara M. Sekihara H. 1998 Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia Clinical Endocrinology 49 377 383
23. Jakubowicz D.J. Beer N.A. Beer R.M. Nestler J.E. 1995 Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women Journal of Clinical Endocrinology and Metabolism 80 3373 3376
24. Yamauchi A. Takei I. Nakamoto S. Ohashi N. Kitamura Y. Tokui M. Nakano S. Takayama S. Kasuga A. Katsukawa F. Saruta T. 1996 Hyperglycemia decreases dehydroepiandrosterone in Japanese male with impaired glucose tolerance and low insulin response Endocrine Journal 43 285 290
25. DeFronzo R.A. Tobin J.D. Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance American Journal of Physiology 237 E214 E223
26. Fiet J. Gosling J.P. Soliman H. Galons H. Boudou P. Aubin P. Belanger A. Villette J.M. Julien R. Brerault J.L. 1994 Hirsutism and acne in women: coordinated radioimmunoassays for eight relevant plasma steroids Clinical Chemistry 40 2296 2305
27. Davidian M. Giltinan D.M. 1995 Nonlinear Models for Repeated Measurement Data In Monographs on Statistics and Applied Probability Chapman & Hall / CRC Boca-Raton 17 21
28. 4 in relation to ischemic heart disease mortality in diabetic subjects Diabetes Care 19 1045 1050
29. Nestler J.E. McClanahan M.A. Clore J.N. Blackard W.G. 1992 Insulin inhibits adrenal 17,20-lyase activity in man Journal of Clinical Endocrinology and Metabolism 74 362 367
30. DECODE Study Group the European Diabetes Epidemiology Group. 2001 Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria Archives of Internal Medicine 161 397 405
31. Oltmanns K.M. Fruehwald-Schultes B. Kern W. Born J. Fehm H.L. Peters A. 2001 Hypoglycemia, but not insulin, acutely decreases LH and T secretion in men Journal of Clinical Endocrinology and Metabolism 86 4913 4919
32. Longcope C. 1995 Metabolism of DHEA Annals of New York Academy of Sciences 774 143 148
33. Thomas N. Morris H.A. Scopacasa F. Wishart J.M. Need A.G. 1999 Relationships between age, dehydro-epiandrosterone sulphate and plasma glucose in healthy men Age and Ageing 28 217 220
34. Couch R.M. 1992 Dissociation of cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus Acta Endocrinologica (Copenh) 127 115 117
35. Arlt W. Haas J. Callies F. Reincke M. Hubler D. Oettel M. Ernst M. Schulte H.M. Allolio B. 1999 Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens Journal of Clinical Endocrinology and Metabolism 84 2170 2176
36. Ferrari E. Cravello L. Muzzoni B. Casarotti D. Paltro M. Solerte S.B. Fioravanti M. Cuzzoni G. Pontiggia B. Magri F. 2001 Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates European Journal of Endocrinology 144 319 329
37. Alberti K.G. Zimmet P.Z. 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Medicine 15 539 553
38. Donatella R.D.E. Fusco L. Falsetti B. 1997 The effects of somatostatin in the polycystic ovary syndrome Journal of Obstetrics and Gynaecology 17 560 564
39. Ciotta L. De Leo V. Galvani F. La Marca A. Cianci A. 1999 Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia Human Reproduction 14 2951 2958
40. Ueshiba H. Shimizu Y. Hiroi N. Yakushiji F. Shimojo M. Tsuboi K. Miyachi Y. 2002 Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus European Journal of Endocrinology 146 375 380
41. Nestler J.E. Clore J.N. Strauss J.F. Blackard W.G. 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans Journal of Clinical Endocrinology and Metabolism 64 180 184
42. Diamond M.P. Grainger D.A. Laudano A.J. Starick-Zych K. DeFronzo R.A. 1991 Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women Journal of Clinical Endocrinology and Metabolism 72 883 887
43. Micic D. Popovic V. Nesovic M. Sumarac M. Dragasevic M. Kendereski A. Markovic D. Djordjevic P. Manojlovic D. Micic J. 1988 Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease Journal of Steroid Biochemistry 31 995 999
44. Moghetti P. Castello R. Negri C. Tosi F. Spiazzi G.G. Brun E. Balducci R. Toscano V. Muggeo M. 1996 Insulin infusion amplifies 17 alpha- hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity Journal of Clinical Endocrinology and Metabolism 81 881 886
45. Nestler J.E. Kahwash Z. 1994 Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans Journal of Clinical Investigation 94 1484 1489
46. Buyalos R.P. Bradley E.L. Jr. Judd H.L. Zacur H.A. Azziz R. 1991 No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease Fertility and Sterility 56 1179 1182